Clinical Studies
Our commitment to evidence-based medicine drives our research agenda. Explore our scientific presentations, published research, and patient-reported outcomes that support our regenerative medicine protocols.
September 8, 2023
MSCs for Traumatic Brain Injury: Current Evidence
VIEW STUDY
July 22, 2023
Wharton's Jelly MSC Isolation and Expansion Protocols
VIEW STUDY
June 27, 2025
Hypoxic Culture vs. Normoxia Standard Culture in Umbilical Cord Mesenchymal Stem Cells: Comparative Analysis of Therapeutic Potential
Comparative study demonstrating enhanced anti-inflammatory and regenerative properties of hypoxia-preconditioned WJ-MSCs.
VIEW STUDYJune 27, 2025
Mesenchymal Stem Cell Therapy in Patients With Diabetes: A Comprehensive Systematic Review and Meta-Analysis
Meta-analysis of clinical trials evaluating safety and efficacy of MSC therapy for Type 1 and Type 2 diabetes mellitus.
VIEW STUDYJune 27, 2025
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Erectile Dysfunction: A Systematic Review
Systematic review of clinical evidence for MSC therapy in the treatment of erectile dysfunction.
VIEW STUDYJune 27, 2025
Do Maternal and Fetal Demographics Affect the Quality of Umbilical Cord-Derived Mesenchymal Stem Cells?
Investigation into donor factors that may influence the quality and potency of WJ-MSCs for therapeutic applications.
VIEW STUDYJune 27, 2025
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Adults With Inflammatory Bowel Disease
Clinical evaluation of MSC therapy for Crohn's disease and ulcerative colitis.
VIEW STUDYJune 27, 2025
Hypoxia-Induced Metabolic Reprogramming in Mesenchymal Stem Cells: Unlocking the Therapeutic Potential
Research exploring how hypoxic preconditioning enhances MSC metabolic pathways for improved therapeutic outcomes.
VIEW STUDYMay 20, 2024
Safety Profile of MSCs Therapy Administered Through Intrathecal Injections for Neurological Conditions
Safety analysis of intrathecal MSC delivery for neurological conditions including MS and spinal cord injury.
VIEW STUDY
March 15, 2025
Patient-Reported Outcomes in Knee Osteoarthritis Following WJ-MSC Intra-articular Injection: 12-Month Follow-Up
12-month follow-up study tracking pain, mobility, and quality of life improvements after MSC knee treatment.
VIEW STUDY
November 8, 2024
Quality of Life Improvements in Multiple Sclerosis Patients Following Intrathecal MSC Therapy
Patient-reported outcomes for MS patients receiving combined IV and intrathecal MSC protocols.
VIEW STUDY
August 22, 2024
Post-Treatment Survey Results: Patient Satisfaction and Functional Outcomes Across All Treatment Categories
Comprehensive patient satisfaction survey covering orthopedic, neurological, autoimmune, and anti-aging treatment programs.
VIEW STUDYCitations and Scientific References
Our treatment protocols are supported by an extensive body of peer-reviewed research. Below is a selection of the references that inform our clinical approach.
Orthopedic & Musculoskeletal
- Song Y, Zhang J, Xu H, et al. Mesenchymal stem cells in knee osteoarthritis treatment: A systematic review and meta-analysis. J Orthop Translat. 2020;24:121-130.
- Cho WS, et al. Mesenchymal Stem Cells Use in the Treatment of Tendon Disorders: A Systematic Review and Meta-Analysis. Ann Rehabil Med. 2021;45(4):274-283.
- Trebinjac S, Gharairi M. Mesenchymal Stem Cells for Treatment of Tendon and Ligament Injuries. Med Arch. 2020;74(5):387-390.
- Kader N, et al. Cell-based therapy in soft tissue sports injuries of the knee: a systematic review. Expert Opin Biol Ther. 2021;21(8):1035-1047.
- Freitag J, et al. Mesenchymal stem cell therapy in the treatment of osteoarthritis: Reparative pathways, safety and efficacy – A review. BMC Musculoskelet Disord. 2016;17:1-13.
- Matas J, et al. Umbilical Cord-Derived MSCs for Knee Osteoarthritis: Repeated MSC Dosing Is Superior. Stem Cells Transl Med. 2019;8:215-224.
- Jo CH, et al. Intra-articular Injection of Mesenchymal Stem Cells for OA of the Knee: A 2-Year Follow-up Study. Am J Sports Med. 2017;45:2774-2783.
- Hernigou P, et al. Biologic augmentation of rotator cuff repair with mesenchymal stem cells improves healing. Int Orthop. 2014;38:1811-1818.
Degenerative Disc Disease
- Leung VY, et al. Mesenchymal stem cells reduce intervertebral disc fibrosis and facilitate repair. Stem Cells. 2014;32(8):2164-2177.
- Centeno C, et al. Treatment of lumbar degenerative disc disease with culture-expanded autologous mesenchymal stem cells. J Transl Med. 2017;15(1):197.
- Noriega DC, et al. Treatment of Degenerative Disc Disease With Allogeneic Mesenchymal Stem Cells: Long-term Follow-up. Transplantation. 2021;105(2):e25-e27.
- Ekram S, et al. Human umbilical cord-derived mesenchymal stem cells reduced pain and inflammation in rat intervertebral disc degeneration. Mol Cell Biochem. 2021;476(8):3191-3205.
Neurological Conditions
- Albu S, et al. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury. Cytotherapy. 2021;23(2):146-156.
- Jaillard A, et al. Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke. Transl Stroke Res. 2020;11(5):910-923.
- Chung JW, et al. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. Neurology. 2021;96(7):e1012-e1023.
- Meng M, et al. Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis. Am J Transl Res. 2018;10(1):212-223.
- Riordan NH, et al. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. J Transl Med. 2018;16(1):57.
- Wang S, et al. Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury. Brain Res. 2013;1532:76-84.
Autism Spectrum Conditions
- Sun JM, et al. Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder. Stem Cells Transl Med. 2020;9(10):1137-1146.
- Lv YT, et al. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med. 2013;11:196.
- Chez M, et al. Safety and Observations from a Placebo-Controlled Crossover Study to Assess Use of Autologous Umbilical Cord Blood Stem Cells for Autism. Stem Cells Transl Med. 2018;7(4):333-341.
- Liu Q, et al. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders. World J Stem Cells. 2019;11(2):55-72.
Autoimmune & Rheumatologic Conditions
- Markov A, et al. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther. 2021;12(1):192.
- Wang L, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192-3202.
- Lv X, et al. Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis. Drug Des Devel Ther. 2021;15:3927-3936.
- Shi X, et al. Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis. Stem Cell Res Ther. 2019;10(1):266.
- Zhang J, et al. Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical Trial. Gut Liver. 2018;12(1):73-78.
Urological Conditions & Erectile Dysfunction
- Yao C, et al. Effects of Stem Cell Therapy on Diabetic Mellitus Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med. 2022;19:21-36.
- Al Demour S, et al. Safety and Efficacy of 2 Intracavernous Injections of Allogeneic Wharton's Jelly-Derived Mesenchymal Stem Cells in Diabetic Patients with ED. Urol Int. 2021;105(11-12):935-943.
- You D, et al. Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction. Cytotherapy. 2021;23(10):931-938.
Diabetes & Endocrine Conditions
- He J, et al. Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis. PLoS One. 2021;16(3):e0247662.
- de Klerk E, Hebrok M. Stem Cell-Based Clinical Trials for Diabetes Mellitus. Front Endocrinol. 2021;12:631463.
- Kamal MM, Kassem DH. Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes. Front Cell Dev Biol. 2020;8:16.
- Carlsson PO, et al. Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015;64(2):587-592.
- Li Y, et al. Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis. Stem Cell Res Ther. 2021;12(1):273.
Gastrointestinal & Inflammatory Conditions
- Ko JZ, Johnson S, Dave M. Efficacy and Safety of Mesenchymal Stem/Stromal Stem Cell Therapy for Inflammatory Bowel Diseases. Biomolecules. 2021;11(1):82.
- Carvello M, et al. Mesenchymal Stem Cells for Perianal Crohn's Disease. Cells. 2019;8(7):764.
- Cao Y, et al. Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review. Stem Cell Res Ther. 2021;12:32.
- Hosseini-Asl SK, et al. Therapeutic Effect of Mesenchymal Stem Cells in Ulcerative Colitis: A Review. J Clin Med. 2020;9(12):3922.
This is a representative selection. Our clinical team maintains a comprehensive database of over 2,000 peer-reviewed references across all condition categories.
The content on our site, educational materials, and any other written content are not intended to replace an evaluation with a qualified healthcare professional and are not intended as medical advice. Individual results may vary. Read our full medical disclaimer.
Ready to Explore Your Treatment Options?
Schedule a free, no-obligation consultation with our regenerative medicine specialists. We treat patients from over 40 countries.
Or call directly: +90 534 856 92 92